一般演題１５

[O15-3] 中等症から重症のクローン病患者に対するグセルクマブ皮下導入療法の有効性と安全性:GRAVITI試験

*久松 理一¹、Remo Panaccione²、Ailsa Hart³、Flavio Steinwurz⁴、Silvio Danese⁵、Qian Cao⁶、Mobolaji Olurinde⁷、Marion L. Vetter⁷、Zijiang Yang⁷、Yuhua Wang⁷、Jewel Johanns⁷、Natalie A. Terry⁷、坂本 武彦⁸、吉越 真一⁸、佐々木 絢子⁸、Bruce E. Sands⁹、Geert D’ Haens¹⁰ (1. 杏林大学医学部消化器内科学、2. University of Calgary, Calgary、3. London North-West University Healthcare NHS Trust、4. Pan American Crohn’s and Colitis Organisation、5. IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele、6. Sir Run Run Shaw Hospital Affiliated with School of Medicine, Zhejiang University、7. Janssen Research & Development, LLC、8. ヤンセンファーマ株式会社、9. Icahn School of Medicine at Mount Sinai、10. Department of Gastroenterology, Amsterdam University Medical Centers)